Lunai Bioworks (LNAI) Exchange Rate Effect (2013 - 2026)
Lunai Bioworks (LNAI) posted quarterly Exchange Rate Effect of -$13029.0 for Q1 2026, up 38.45% year-over-year from -$9410.8 in Q1 2025, and down 21.63% quarter-over-quarter from -$10712.0 in Q4 2025.
Lunai Bioworks (LNAI) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Lunai Bioworks' Exchange Rate Effect history runs 14 years deep, the most recent figure standing at -$13029.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 38.45% year-over-year to -$13029.0; the TTM figure through Mar 2026 stood at -$192492.0 (down 192.66% YoY), while the FY2025 annual figure was -$135892.0, down 325.96% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$13029.0, down from -$10712.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $153078.0 in Q1 2024, with the low at -$161912.0 in Q2 2025.
- The 5-year median for Exchange Rate Effect is -$6839.0 (2025), against an average of -$6766.4.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect soared 3707.24% in 2022, then tumbled 3638.57% in 2023.
- Lunai Bioworks' Exchange Rate Effect stood at $22082.0 in 2022, then soared by 251.41% to $77598.0 in 2023, then declined by 22.76% to $59938.0 in 2024, then tumbled by 117.87% to -$10712.0 in 2025, then fell by 21.63% to -$13029.0 in 2026.
- Business Quant data shows LNAI's Exchange Rate Effect at -$13029.0 in Q1 2026, -$10712.0 in Q4 2025, and -$6839.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | -13,029.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,029.00 |
| Mar 31, 2026 | -13,029.00 |
| Dec 31, 2025 | -10,712.00 |
| Dec 31, 2025 | -10,712.00 |
| Sep 30, 2025 | -6,839.00 |
| Sep 30, 2025 | -6,839.00 |
| Jun 30, 2025 | -161,912.00 |
| Jun 30, 2025 | -161,912.00 |
| Mar 31, 2025 | -21,167.00 |
| Mar 31, 2025 | -21,167.00 |
| Dec 31, 2024 | 59,938.00 |
| Dec 31, 2024 | 59,938.00 |
| Sep 30, 2024 | -12,751.00 |
| Sep 30, 2024 | -12,751.00 |
| Jun 30, 2024 | -91,794.00 |
| Jun 30, 2024 | -91,794.00 |
| Mar 31, 2024 | 153,078.00 |
| Mar 31, 2024 | 153,078.00 |
| Dec 31, 2023 | 77,598.00 |
| Dec 31, 2023 | 77,598.00 |